Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9441 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9441 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9441 |
High Similarity |
NPD6166 |
Phase 2 |
0.9241 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9177 |
High Similarity |
NPD1934 |
Approved |
0.9036 |
High Similarity |
NPD7054 |
Approved |
0.8982 |
High Similarity |
NPD7074 |
Phase 3 |
0.8982 |
High Similarity |
NPD7472 |
Approved |
0.8931 |
High Similarity |
NPD4380 |
Phase 2 |
0.8882 |
High Similarity |
NPD2801 |
Approved |
0.8824 |
High Similarity |
NPD7808 |
Phase 3 |
0.8817 |
High Similarity |
NPD6797 |
Phase 2 |
0.8817 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8788 |
High Similarity |
NPD6959 |
Discontinued |
0.8773 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8765 |
High Similarity |
NPD7251 |
Discontinued |
0.875 |
High Similarity |
NPD3818 |
Discontinued |
0.8712 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8698 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8671 |
High Similarity |
NPD1511 |
Approved |
0.8606 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8605 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8598 |
High Similarity |
NPD3817 |
Phase 2 |
0.8562 |
High Similarity |
NPD1512 |
Approved |
0.8545 |
High Similarity |
NPD3882 |
Suspended |
0.8521 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD5494 |
Approved |
0.85 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.85 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8494 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.848 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8415 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8402 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8364 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8363 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8291 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8291 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8229 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8212 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8113 |
Intermediate Similarity |
NPD2796 |
Approved |
0.805 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8047 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8034 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8034 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7988 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7952 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7923 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7911 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7831 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7816 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7803 |
Intermediate Similarity |
NPD919 |
Approved |
0.7799 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7754 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7714 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7702 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7688 |
Intermediate Similarity |
NPD943 |
Approved |
0.768 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.767 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.765 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7598 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7588 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7576 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7539 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7539 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7539 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7539 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7539 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7539 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7539 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7539 |
Intermediate Similarity |
NPD6778 |
Approved |
0.753 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7528 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7515 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD37 |
Approved |
0.7486 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7486 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7486 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7474 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7474 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.746 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.746 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD3226 |
Approved |
0.744 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7438 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7427 |
Intermediate Similarity |
NPD920 |
Approved |
0.7424 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7424 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7423 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7423 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7412 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7398 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7377 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7318 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD447 |
Suspended |
0.731 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7289 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7286 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7282 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7277 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7268 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7243 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7212 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7202 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7202 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7121 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7119 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7112 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7088 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7088 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7088 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7076 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7071 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7035 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7015 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD7003 |
Approved |
0.6971 |
Remote Similarity |
NPD6273 |
Approved |
0.697 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6968
|
Remote Similarity |
NPD7038 |
Approved |